Anti-CD146 Linked to Silica in Systemic Sclerosis

• by Kathryn Wighton

• March 5, 2026

FDA Approves Atacicept for IgA Nephropathy

The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.

• by Kathryn Wighton

• July 7, 2026

• 3 min

How Epstein Barr virus shapes lupus autoimmunity: mechanistic insights and therapeutic perspectives

• by Rada Miskovic, Ivica Jeremic, Danijela Miljanovic, Andja Cirkovic, Ana Banko

• June 2, 2026

Type I interferon pathway activation in connective tissue disease associated interstitial lung disease

• by Tobias M. Defesche, Thomas Koudstaal, Marjan A. Versnel, Odilia B.J. Corneth, Zana Brkic

• June 11, 2026